Although fasting triglyceride (TG) levels are routinely measured in clinical practice, studies indicate that postprandial hypertriglyceridemia may be also related to atherosclerosis [1]. Currently, there are expert panel statements [2] and guidelines [3] stating that non-fasting TG levels are clinically valid and that postprandial TG (pTG) measurements may be useful to evaluate cardiovascular (CV) risk.
